# Cognitive Health at 90 Shows Persistent Disparities, But Some Defy Risk Factors
Researchers tracking people over 90 have identified a paradox: reaching advanced age without dementia does not erase lifelong patterns of disease risk. The study reveals that sex, race and genetic inheritance continue to shape dementia vulnerability even among the oldest-old, while some individuals demonstrate remarkable cognitive resilience despite carrying multiple established risk factors.
The research documents what epidemiologists call the "healthy survivor effect." People who live into their nineties represent a selected group, yet this longevity masks ongoing biological and social inequities. Women in this age group face notably elevated dementia risk compared to men of the same age, contradicting the common assumption that reaching 90 signals immunity from the disease. Black participants similarly showed higher dementia prevalence, reflecting patterns established decades earlier in life.
Genetic predisposition remains a powerful predictor even at extreme ages. Carriers of the APOE4 gene variant, a well-established Alzheimer's disease risk allele, continued to show elevated cognitive decline in their nineties and beyond. Yet the research uncovered something unexpected: a subset of study participants possessed major genetic and biological risk factors but maintained normal cognition. These individuals defied the standard disease trajectory.
This divergence between risk and outcome presents a genuine scientific puzzle. Some possibilities merit investigation. Cognitive reserve—the brain's capacity to maintain function despite pathological changes—may protect certain individuals. Others might possess unrecognized genetic protective factors, unknown metabolic advantages, or have engaged in lifestyle practices that buffered them against decline. Environmental factors such as education, social engagement, physical activity and cognitive stimulation accumulate over decades and could explain why some high-risk individuals escape dementia.
The findings arrive amid growing recognition that dementia is not a single disease but a heterogeneous condition with multiple pathways to cognitive impairment. Two people with identical pathology can experience different functional outcomes. Understanding why some brains resist dementia better than others requires moving beyond risk factor epidemiology toward mechanistic research.
These results carry clinical weight. They suggest that reaching 90 without dementia does not guarantee future cognitive health, particularly for women and Black older adults who face persistent vulnerability. Healthcare systems should not lower screening vigilance in these populations. Simultaneously, the study of "outliers"—those who defy predictions—offers a research frontier. Identifying protective mechanisms in cognitively healthy people with high genetic burden could inform interventions for younger populations at risk.
The research also highlights health equity gaps embedded across the lifespan. Sex and race-based disparities in dementia risk reflect upstream differences in education access, healthcare quality, cardiovascular health management and economic resources. Addressing these patterns requires policies that extend beyond individual-level interventions.
Future studies should examine the neurobiology of these resilient individuals through imaging, biomarker analysis and genetic sequencing. Understanding how some brains compensate for Alzheimer's pathology or genetic risk could reveal therapeutic targets applicable to broader populations. The oldest-old population offers a natural laboratory for studying successful aging, provided researchers look carefully at who achieves it and why.